AMA Urges Tighter Restrictions for E-Cigarette Sales

Share this content:
AMA Urges Tighter Restrictions for E-Cigarette Sales
AMA Urges Tighter Restrictions for E-Cigarette Sales

(HealthDay News) -- The American Medical Association (AMA) on Tuesday called for tighter restrictions on the sale and marketing of electronic cigarettes.

Among the new recommendations are a minimum age purchase rule; child-proof and tamper-proof packaging; restrictions on flavors that appeal to young people; more extensive product labels; and a ban on unsupported claims that the devices help people quit smoking. 

The group also wants the federal government to force e-cigarette makers to provide details about the design, content, and emissions of the devices, and to boost efforts to prevent marketing of e-cigarettes to minors.

RELATED: E-Cigarettes: 'Pathway' to Tobacco Cessation or 'Dangerous Product'?

The new AMA policy extends the group's existing policy that was adopted in 2010 and calls for the U.S. Food and Drug Administration (FDA) to subject all e-cigarettes to the same regulations and oversight applied to tobacco and nicotine products.

"The AMA supports an FDA proposal to fill the gap in federal regulations on purchasing, labeling, packaging, and advertising of electronic cigarettes," incoming AMA President Robert Wah, MD, said in a news release from the group. 

"The new policy will guide the AMA's future efforts to strongly encourage the proposed FDA regulation as a notable and important step to improve public health and deter the sale of electronic cigarettes to minors," he added. 

"Improving the health of the nation is AMA's top priority and we will continue to advocate for policies that help reduce the burden of preventable diseases like cardiovascular disease and type 2 diabetes, which can both be linked to smoking."

To read more, click here.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs